Literature DB >> 18570972

Hsp90 inhibitors reduce influenza virus replication in cell culture.

Geoffrey Chase1, Tao Deng, Ervin Fodor, Bo Wah Leung, Daniel Mayer, Martin Schwemmle, George Brownlee.   

Abstract

The viral RNA polymerase complex of influenza A virus consists of three subunits PB1, PB2 and PA. Recently, the cellular chaperone Hsp90 was shown to play a role in nuclear import and assembly of the trimeric polymerase complex by binding to PB1 and PB2. Here we show that Hsp90 inhibitors, geldanamycin or its derivative 17-AAG, delay the growth of influenza virus in cell culture resulting in a 1-2 log reduction in viral titre early in infection. We suggest that this is caused by the reduced half-life of PB1 and PB2 and inhibition of nuclear import of PB1 and PA which lead to reduction in viral RNP assembly. Hsp90 inhibitors may represent a new class of antiviral compounds against influenza viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18570972     DOI: 10.1016/j.virol.2008.04.040

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  67 in total

1.  Inhibition of heat-shock protein 90 reduces Ebola virus replication.

Authors:  Darci R Smith; Sarah McCarthy; Andrew Chrovian; Gene Olinger; Andrea Stossel; Thomas W Geisbert; Lisa E Hensley; John H Connor
Journal:  Antiviral Res       Date:  2010-05-07       Impact factor: 5.970

2.  Identification of BPR3P0128 as an inhibitor of cap-snatching activities of influenza virus.

Authors:  John T-A Hsu; Jiann-Yih Yeh; Ta-Jen Lin; Mei-Ling Li; Ming-Sian Wu; Chung-Fan Hsieh; Yao Chieh Chou; Wen-Fang Tang; Kean Seng Lau; Hui-Chen Hung; Ming-Yu Fang; Shengkai Ko; Hsing-Pang Hsieh; Jim-Tong Horng
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

Review 3.  Uncovering the global host cell requirements for influenza virus replication via RNAi screening.

Authors:  Silke Stertz; Megan L Shaw
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

4.  Targeting of the influenza A virus polymerase PB1-PB2 interface indicates strain-specific assembly differences.

Authors:  Peter Reuther; Benjamin Mänz; Linda Brunotte; Martin Schwemmle; Kerstin Wunderlich
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

5.  Association of the influenza virus RNA polymerase subunit PB2 with the host chaperonin CCT.

Authors:  Tatiana Fislová; Benjamin Thomas; Katy M Graef; Ervin Fodor
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

Review 6.  High-throughput RNA interference screens integrative analysis: Towards a comprehensive understanding of the virus-host interplay.

Authors:  Sandeep Amberkar; Narsis A Kiani; Ralf Bartenschlager; Gualtiero Alvisi; Lars Kaderali
Journal:  World J Virol       Date:  2013-05-12

7.  Nuclear import and assembly of influenza A virus RNA polymerase studied in live cells by fluorescence cross-correlation spectroscopy.

Authors:  Sébastien Huet; Sergiy V Avilov; Lars Ferbitz; Nathalie Daigle; Stephen Cusack; Jan Ellenberg
Journal:  J Virol       Date:  2009-11-11       Impact factor: 5.103

8.  Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.

Authors:  Xiaoping Sun; Elizabeth A Barlow; Shidong Ma; Stacy R Hagemeier; Sarah J Duellman; Richard R Burgess; Judy Tellam; Rajiv Khanna; Shannon C Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-26       Impact factor: 11.205

9.  Heat shock protein 70 inhibits HIV-1 Vif-mediated ubiquitination and degradation of APOBEC3G.

Authors:  Ryuichi Sugiyama; Hironori Nishitsuji; Ayako Furukawa; Masato Katahira; Yuichiro Habu; Hiroaki Takeuchi; Akihide Ryo; Hiroshi Takaku
Journal:  J Biol Chem       Date:  2011-01-12       Impact factor: 5.157

10.  A quantitative strategy to detect changes in accessibility of protein regions to chemical modification on heterodimerization.

Authors:  Mathias Dreger; Bo Wah Leung; George G Brownlee; Tao Deng
Journal:  Protein Sci       Date:  2009-07       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.